Headquartered in Murray Hill, New Jersey, USA, C R Bard is a leading manufacturer and developer of a wide range of medical products and technologies. Founded in 1907, in New York by Charles R. Bard, today C R Bard or simply Bard is a global healthcare company that develops and markets cutting-edge medical technologies and products. Bard focuses on providing innovative services, improving clinical outcomes and enhancing patients’ satisfaction. It specialises in vascular, oncology, urology disease management and surgical operations. Included to the S&P 500 component, the C R Bard share price is traded on the NYSE.